Parameter | Estrogens group* (n = 34) | Placebo group (n = 33) | P-value | ||
---|---|---|---|---|---|
Week 0 | Week 12 | Week 0 | Week 12 | ||
FSFI: Total a | 20.31 ± 4.93 | 25.14 ± 4.74 | 22.27 ± 5.03 | 24.32 ± 4.83 | 0.182 |
 FSFI: Desire a | 2.44 ± 0.82 | 3.12 ± 0.76 | 2.73 ± 0.65 | 2.90 ± 0.64 | 0.218 |
 FSFI: Arousal a | 2.72 ± 1.06 | 3.46 ± 0.97 | 3.03 ± 1.28 | 3.25 ± 0.91 | 0.133 |
 FSFI: Lubrication a | 3.46 ± 1.27 | 4.54 ± 1.16 | 3.98 ± 1.04 | 4.20 ± 1.03 | 0.057 |
 FSFI: Orgasm a | 3.93 ± 1.14 | 4.26 ± 1.24 | 4.10 ± 1.12 | 4.62 ± 1.16 | 0.365 |
 FSFI: Satisfaction a | 4.06 ± 1.02 | 4.63 ± 0.88 | 4.52 ± 0.85 | 4.69 ± 0.99 | 0.219 |
 FSFI: Pain a | 3.71 ± 1.87 | 5.13 ± 0.95 | 3.90 ± 1.51 | 4.66 ± 1.05 | 0.067 |
Vaginal pHc | 6.0 (5.5–8.0) | 5.0 (4.0–6.0) | 6.0 (5.5–6.0) | 7.0 (6.0–8.0) | < 0.001 |
Normal Flora Indexc | 5 (3–6) | 6 (4–10) | 4 (3–6) | 6 (4–6) | 0.282 |
Vaginal Maturation Valuec | 15 (0–53.75) | 57.5 (38.75–65) | 20 (1.25–51.25) | 20 (0.63–46.88) | < 0.001 |
Superficial cellc | 0 (0–1) | 0.5 (1.5–3) | 0 (0–2.5) | 0 (0–0.88) | < 0.001 |
MBS, totalc | 4 (3–6) | 2 (0–3) | 5 (3–7) | 3 (1–4) | 0.182 |
 Vaginal drynessc | 2 (2–3) | 1 (0–2) | 2 (2–3) | 1 (0–2) | 0.858 |
 Vaginal/vulvar irritation/itchingc | 0 (0–2) | 0 (0–0) | 1 (0–2) | 0 (0–1) | 0.190 |
 vaginal/vulvar sorenessc | 0 (0–1) | 0 (0–0) | 0 (0–2) | 0 (0–1) | 0.204 |
 Dyspareuniac | 2 (1–3) | 0 (0–1) | 2 (1–2) | 1 (0–1) | 0.152 |